The Political Architecture of Obesity: What a Tobacco-Scale Response Would Actually Require

Australia does not have an obesity knowledge problem. It has an obesity architecture problem.

The epidemiological case has been settled for years. Overweight and obesity is now Australia's leading modifiable risk factor for disease burden, responsible for 8.3 per cent of all healthy years of life lost — overtaking tobacco, which has fallen to 7.6 per cent following four decades of sustained, multi-level regulatory intervention (AIHW, 2024). Two in three adults and one in four children are affected (ABS, 2024). The annual economic cost is estimated at $45 billion, including $7 billion in direct health system expenditure (AIHW, 2025; PharmaDispatch, 2026). None of this is news to anyone reading this article.

What remains absent is the regulatory and fiscal architecture required to act on it.

The National Obesity Strategy 2022–2032 and the National Preventive Health Strategy 2021–2030 both identify the right priorities. Neither provides the legislative instruments, the fiscal mechanisms, or the governance structure to deliver them. They signal intent. They do not compel action. On current trajectory, Australia will not meet any of the NPHS obesity targets by 2030 — not the target to halt and reverse adult obesity, not the target to reduce childhood overweight by five per cent, and not the target to lift preventive health investment to five per cent of total health expenditure.

This article describes what a credible acceleration framework would require — one that sits alongside existing strategies and supplies the regulatory teeth they currently lack. It does not pretend that building this architecture is straightforward. The barriers are real, well-documented, and predominantly political. But they are also finite and navigable, as Australia's own tobacco control history demonstrates.

What Tobacco Control Actually Teaches

The tobacco analogy is commonly invoked in obesity policy discussions. It is less commonly interrogated for what it actually explains.

Australia's tobacco regime succeeded not because of any single measure, but because it operated as a mutually reinforcing system sustained over three decades (Scollo & Winstanley, 2024). Excise taxation reduced affordability. Advertising bans removed cultural normalisation. Graphic package warnings communicated risk at point of sale. Smoke-free legislation restructured the physical environment. Mass media campaigns maintained public salience. Clinical cessation pathways — the Quitline, nicotine replacement therapy on the PBS — provided accessible exit routes.

The critical insight is not the list of instruments. It is the systems logic. Tobacco control recognised that individual behaviour change is structurally constrained by the commercial environment. Asking people to quit smoking while tobacco was cheap, heavily marketed, and permitted in every indoor space was a failure of policy design, not a failure of individual willpower.

The current approach to obesity occupies precisely that pre-reform position. We ask individuals to make healthier choices in an environment saturated with cheap, heavily marketed, ultra-processed food. We rely on voluntary industry codes that multiple independent evaluations have found ineffective (Ngqangashe et al., 2024). We fund episodic campaigns while the food and beverage industry spends orders of magnitude more on advertising. We cap allied health access at five sessions per year while the clinical need is chronic and complex.

However, the analogy has limits that must be named. Tobacco is a single product with no health benefit at any level of consumption. Food is essential, diverse, and culturally embedded. Nobody needs to quit eating. The regulatory instruments must therefore target the food environment — the commercial systems that make the unhealthy choice the default choice — rather than food itself. This distinction matters enormously for political framing, and advocates who elide it make the policy harder to advance.

Seven Pillars: What the Architecture Looks Like

A credible response can be structured across seven intersecting pillars. They are presented here not as a wish list, but as a sequenced regulatory programme.

Pillar 1 — A tiered SSB health levy. A national excise on sugar-sweetened beverages, tiered by sugar content (for example, 40 cents per litre for drinks containing 5–8 grams of sugar per 100mL; 60 cents above that threshold), administered by the ATO and fully hypothecated to a National Obesity Prevention Fund (Grattan Institute, 2024). Australia is an outlier on this policy. More than 64 countries have implemented SSB taxes for health purposes (WHO, 2024). The evidence from the UK, Mexico, and South Africa consistently demonstrates reduced purchasing and rapid product reformulation — the UK's tiered Soft Drinks Industry Levy drove a 42.7 per cent reduction in sugar content before the tax took effect (Colchero et al., 2017; Prowse et al., 2025). The equity objection — that consumption taxes are financially regressive — is addressed by the evidence that low-income populations achieve the largest consumption reductions and therefore the greatest health benefit, and by hypothecation of 100 per cent of revenue to prevention programs in disadvantaged communities (Briggs et al., 2017).

Pillar 2 — Mandatory interpretive warning labels. Transitioning from the voluntary Health Star Rating to mandatory front-of-pack warning labels for products exceeding sugar, saturated fat, and sodium thresholds — modelled on Chile's black octagon system, which produced significant reductions in purchases of high-sugar products and a 20 per cent rate of voluntary industry reformulation (Taillie et al., 2020; Reyes et al., 2020). Interpretive labels outperform algorithm-based rating systems in consumer comprehension, particularly for populations with lower health literacy (Neal et al., 2017; Kelly et al., 2018).

Pillar 3 — Statutory food marketing restrictions. A legislated ban on unhealthy food marketing to children across broadcast, digital, and sponsorship channels. The evidence is unequivocal: a 2025 systematic review confirms that food marketing causally increases food intake, preferences, and purchasing in children (Boyland et al., 2025). Voluntary self-regulation has failed — this is not a contested finding but a repeatedly demonstrated one (Ngqangashe et al., 2024; Gage et al., 2024). The UK has legislated a comprehensive online and pre-watershed television ban through the Health and Care Act 2022, providing a directly transferable precedent (Harris et al., 2025; Thow et al., 2023). Children from lower socioeconomic backgrounds carry disproportionate exposure.

Pillar 4 — Healthy food environment legislation. Urban planning controls on fast-food outlet density (particularly around schools) and mandatory healthy food procurement standards for Commonwealth-funded institutions. The evidence linking proximity to fast-food outlets with higher obesity prevalence is consistent (Burgoine et al., 2014; Hobbs et al., 2019), and procurement reform has demonstrated rapid improvements in institutional food quality (Stefani et al., 2015; WHO, 2022). Fast-food outlet concentration is heavily skewed toward low-SES areas, making this the most directly equity-targeted pillar.

Pillar 5 — A national clinical pathway. Medicare-funded obesity assessment (new MBS items), removal of the five-session allied health cap for obesity management, public hospital bariatric surgery capacity, and a clinical governance framework for the equitable prescribing of GLP-1 receptor agonists under the PBS (RACGP, 2024). The GLP-1 RA question deserves particular honesty: the clinical trial evidence for semaglutide and tirzepatide is striking (15–22 per cent mean weight loss; cardiovascular benefit), but long-term durability data is limited, weight regain on cessation is significant, and the fiscal exposure of unrestricted PBS listing is substantial. A clinical governance framework with defined eligibility criteria, specialist initiation, and regular PBS review is essential — not to restrict access, but to ensure that access is equitable and sustainable, preventing a two-tier system where effective treatment is available only to those who can pay privately.

Pillar 6 — Sustained national social marketing. A centrally funded, continuous campaign modelled on the National Tobacco Campaign — not the fragmented, state-based, episodically funded model that currently exists. This requires a ten-year commitment at $50–80 million annually. Western Australia's LiveLighter initiative provides a strong local precedent (Deakin University, 2024), but mass media without accompanying environmental and regulatory change is expensive wallpaper. The campaign must be systems-framed, avoiding individual blame. And it must include dedicated streams co-designed with Aboriginal Community Controlled Health Organisations and CALD community leaders — a single national message will not reach priority populations.

Pillar 7 — A national surveillance system. Continuous monitoring of dietary intake, physical activity, weight status, and food environment exposure, housed within the AIHW and linked to MBS, PBS, and hospital administrative data. Australia's last comprehensive national nutrition survey was conducted in 2011–12 — a 15-year gap that the NPHS itself identifies as critical. Tobacco control's capacity to calibrate and adjust relied on continuous surveillance. You cannot manage a $45 billion crisis on triennial snapshots. All reporting must be disaggregated by SEIFA (Socio-Economic Indexes for Areas) quintile, geographic remoteness, and Indigeneity.

Why It Has Not Happened

Listing the seven pillars is the easy part. Understanding why they remain unbuilt — despite decades of advocacy by some of Australia's most credible public health institutions — is the harder and more important question.

Three structural barriers explain the gap.

First, the commercial determinants are formidable. The food and beverage industry — particularly the ultra-processed food and SSB sectors — operates with structural incentives to maximise the sale of energy-dense, nutrient-poor products. This is not a conspiracy; it is a market logic. The industry has deployed well-documented strategies to delay and dilute regulatory action: funding sympathetic research, promoting voluntary self-regulation as a substitute for legislation, framing regulation as "nanny state" overreach, and positioning itself as a co-design partner in the policy process (Ngqangashe et al., 2024). In tobacco control, Australia eventually recognised that the industry's commercial interests are fundamentally misaligned with public health and moved to a regulated-actor model. In food policy, that transition has not yet occurred.

Second, the complexity is genuine. Tobacco is a single product with no safe level of consumption. Food is essential, culturally diverse, and commercially fragmented. The regulatory instruments cannot ban the product. They must instead reshape the environment in which food is produced, marketed, sold, and consumed — a more complex regulatory task that spans Commonwealth, state, and local government jurisdictions, and that requires consensus mechanisms (like the Food Ministers' Meeting) with well-documented histories of delay. Advocates who dismiss this complexity make the policy harder to pass, not easier.

Third, the political window is narrow and must be used precisely. Tobacco control was not built in a single electoral cycle. It was sequenced over decades, with each reform building the political capital for the next. The failure of previous advocacy efforts has often been one of sequencing — presenting the full architecture simultaneously and inviting opponents to attack the most politically exposed element.

This framework proposes a phased, 10-year roadmap across three waves. Wave 1 (Years 1–2) establishes the fiscal instrument, the governance authority, and the marketing watershed — measures with the highest public support and the strongest evidence base. Wave 2 (Years 2–4) extends the regulatory reach to digital marketing, interpretive labels, and clinical pathway reform. Wave 3 (Years 5–10) matures and embeds the system, evaluates impact, and builds the case for further measures based on Australian evidence. This staging is not a compromise. It is the strategy.

The Fiscal Architecture

The scale of the proposed investment ($420–670 million annually across all pillars) may appear daunting against current preventive health budgets. It is not.

An SSB levy at conservative Grattan Institute rates would generate approximately $500 million in its first year (Grattan Institute, 2024). Under broader modelling assumptions, revenue could reach $850 million to $1 billion (Australian Medical Association, 2025). Even the conservative estimate is sufficient to fund the entire intervention architecture and deliver a net budget surplus.

Revenue would decline over time as reformulation and consumption reduction take effect — an outcome that represents health success, not fiscal failure. The framework budgets for this trajectory, maintaining a steady-state investment of $350–400 million annually from Year 5 onward.

This is what a fiscally credible response looks like: self-funding, with a transparent revenue-to-outcome logic that Treasury can scrutinise.

Equity as Architecture, Not Appendix

The burden of obesity follows Australia's fault lines of disadvantage with depressing precision. It is highest in the lowest SEIFA quintiles, in outer regional and remote communities, and among Aboriginal and Torres Strait Islander peoples, for whom obesity intersects with the ongoing effects of colonisation, disrupted traditional food systems, and systemic food insecurity (ABS, 2024; AIHW, 2024).

Generic population-level policy risks a familiar failure: improving average outcomes while leaving the most disadvantaged behind. This framework addresses that risk structurally.

Fund allocation is weighted by SEIFA disadvantage. Ten per cent of total revenue is directed to ACCHO-led programs. The clinical pathway mandates telehealth and outreach models for MMM 3–7 communities where specialist access is otherwise absent. Surveillance reporting is disaggregated by socioeconomic status, geography, and Indigeneity — because if the data cannot show whether equity gaps are closing, the architecture has failed.

For First Nations communities specifically, the framework aligns with the National Agreement on Closing the Gap (2020) and applies AIATSIS CARE Principles for Indigenous data sovereignty. First Nations clinical pathways, social marketing, and community programs are not adapted from mainstream designs — they are community-controlled and ACCHO-delivered. This is not an optional equity layer. It is a governance requirement.

How This Framework Was Built

This policy architecture is an applied analysis produced by Percova. It was not assembled by summarising the literature and listing recommendations.

The brief was decomposed into its full dependency structure: epidemiological burden, evidence synthesis across seven regulatory domains, health economic modelling, legislative sequencing, political feasibility assessment, and stakeholder analysis. These disciplines were then activated in parallel, with each analytical layer cross-referencing the others. The investment case was stress-tested against the political feasibility assessment. The clinical pathway was costed against the fiscal model. The implementation roadmap was sequenced against the stakeholder map.

The result is a framework where the evidence, the economics, the politics, and the governance have been held against each other simultaneously — not presented in parallel silos. The gaps between what the evidence supports, what the fiscal model can fund, and what the political landscape will tolerate are made explicit, not papered over.

At Percova, this is not an optional enhancement. It is the method.

References